Cargando…
Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations
Background: In recent years, blood eosinophils have been evaluated as a surrogate biomarker for eosinophilic airway inflammation and as a prognostic indicator of the outcomes of hospitalized COPD subjects. During an exacerbation of COPD, eosinopenia has been proposed as a prognostic marker of advers...
Autores principales: | Bartziokas, Konstantinos, Papathanasiou, Evgenia, Papaioannou, Andriana I., Papanikolaou, Ilias, Antonakis, Emmanouil, Makou, Ioanna, Hillas, Georgios, Karampitsakos, Theodoros, Papaioannou, Ourania, Dimakou, Katerina, Apollonatou, Vasiliki, Verykokou, Galateia, Papiris, Spyros, Bakakos, Petros, Loukides, Stelios, Kostikas, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145416/ https://www.ncbi.nlm.nih.gov/pubmed/37109072 http://dx.doi.org/10.3390/jpm13040686 |
Ejemplares similares
-
Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control
por: Tsilogianni, Zoi, et al.
Publicado: (2015) -
Exhaled breath condensate pH as a biomarker of COPD severity in ex-smokers
por: Papaioannou, Andriana I, et al.
Publicado: (2011) -
IL-26 in the Lung and Its Role in COPD Inflammation
por: Bartziokas, Konstantinos, et al.
Publicado: (2022) -
Revisiting IL-13 blockade: can we reach the wonderland the inhaled way?
por: Papaioannou, Andriana I., et al.
Publicado: (2018) -
Sestrin 2 levels are associated with emphysematous phenotype of COPD
por: Angelakis, Leonidas, et al.
Publicado: (2022)